Showing results (381-390 of 483) with videos related to

Sort By:
Pageof 49
Circulation Research|April 2, 2024
Endothelial PTP1B Deletion Promotes VWF Exocytosis and Venous ThromboinflammationKonstantinos Zifkos, Magdalena L Bochenek, Rajinikanth Gogiraju, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 24, 2025
Time- and dose-dependent high-sensitivity cardiac troponin-T to improve outcome prediction after TAVI: a multicenter cohort studyThorald Stolte, Jakob Johannes Reichl, Pedro Lopez-Ayala, et al.
Frontiers in Cardiovascular Medicine|July 16, 2026
Progression of mitral and tricuspid regurgitation in patients with and without atrial fibrillationMichael Koechlin, Rebecca E Paladini, Stefanie Aeschbacher, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 8, 2021
Changes in blood pressure after crossover to ultrasound renal denervation in patients initially treated with sham in the RADIANCE-HTN SOLO trialFelix Mahfoud, Michael J Bloch, Michel Azizi, et al.
Journal of Hypertension|July 15, 2021
European Society of Hypertension position paper on renal denervation 2021Roland E Schmieder, Felix Mahfoud, Giuseppe Mancia, et al.
Lancet (London, England)|May 28, 2018
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trialDavid E Kandzari, Michael Böhm, Felix Mahfoud, et al.
American Heart Journal|December 26, 2025
Large-bore mechanical thrombectomy vs standard of care for acute high-risk pulmonary embolism: rationale and design of the PERSEVERE randomized controlled trialRomain Chopard, Lukas Hobohm, Stefano Barco, et al.
Journal of Hypertension|March 2, 2011
Renal denervation: a potential new treatment modality for polycystic ovary syndrome?Markus P Schlaich, Nora Straznicky, Mariee Grima, et al.
The American Journal of Cardiology|February 9, 2026
Radial versus femoral secondary access in patients undergoing TAVI - Rationale and Design of the RADIAL-TAVI trialAlexander von Ehr, Uwe Zeymer, Steffen Schneider, et al.
European Heart Journal|December 28, 2018
Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trialsMichael Böhm, Helmut Schumacher, Koon K Teo, et al.
Pageof 49